In the present study, we investigated the in vitro effect of saucernetin-7, which is a dineolignan isolated from Saururus chinensis, on the proliferation, cell cycle-regulation and differentiation of HL-60 human promyelocytic leukemia cells. Saucernetin-7 potently inhibited the proliferation of HL-60 cells in both a dose-and time-dependent manner with an IC 50 ,~5 mM. DNA flow-cytometry indicated that saucernetin-7 markedly induced a G 1 phase arrest of HL-60 cells. Among the G 1 phase cell cyclerelated proteins, the levels of cyclin-dependent kinase (CDK)6 and cyclin D1 were reduced by saucernetin-7, whereas the steady-state levels of CDK2, CDK4, cyclin D2, cyclin D3 and cyclin E were unaffected. The protein and mRNA levels of a CDK inhibitor p21
In the present study, we investigated the in vitro effect of saucernetin-7, which is a dineolignan isolated from Saururus chinensis, on the proliferation, cell cycle-regulation and differentiation of HL-60 human promyelocytic leukemia cells. Saucernetin-7 potently inhibited the proliferation of HL-60 cells in both a dose-and time-dependent manner with an IC 50 ,~5 mM. DNA flow-cytometry indicated that saucernetin-7 markedly induced a G 1 phase arrest of HL-60 cells. Among the G 1 phase cell cyclerelated proteins, the levels of cyclin-dependent kinase (CDK)6 and cyclin D1 were reduced by saucernetin-7, whereas the steady-state levels of CDK2, CDK4, cyclin D2, cyclin D3 and cyclin E were unaffected. The protein and mRNA levels of a CDK inhibitor p21
CIP1aWAF1 , but not p27 KIP1 , were markedly increased by saucernetin-7 and p21
CIP1aWAF1 induction is likely to occur at the transcriptional level because actinomycin D blocked this induction. In addition, saucernetin-7 markedly enhanced the binding of p21
CIP1aWAF1 with CDK2 and CDK6, resulting in the reduced activity of both kinases and the hypophosphorylation of Rb protein. We furthermore suggest that saucernetin-7 is a potent inducer of the differentiation of HL-60 cells, based on observations such as a reduction of the nitroblue tetrazolium level, an increase in the esterase activities and phagocytic activity, morphology changes, and the expression of CD14 and CD66b surface antigens.
In conclusion, the onset of saucernetin-7-induced the G 0 /G 1 arrest of HL-60 cells prior to the differentiation is linked to a sharp up-regulation of the p21
CIP1aWAF1 level and a decrease in the CDK2 and CDK6 activities. This is the first report demonstrating that saucernetin-7 potently inhibits the proliferation of human promyelocytic HL-60 cells via the G 1 phase cell cycle arrest and differentiation induction.
Introduction
Hematopoietic tumors often arise as a consequence of the uncontrolled proliferation of immature blasts and eventually fail to terminally differentiate into mature blood cells (1) . Therefore, the engagement of a maturation program requires the arrest of the proliferating cell cycle (2) . The cell cycle in eukaryotes is regulated by cyclin-dependent kinases (CDKs). CDK4 and CDK6 are thought to be involved in early G 1 , whereas CDK2 is required to complete G 1 and initiate S phase (3) . By controlling the level of CDK activity, the CDK regulators can also control the cell cycle-commitment (4) . These include activators such as the cyclins as well as the inhibitors generally known as CKIs (CDKs inhibitors). To date, there are two known classes of mammalian CKIs. One group is the CIP/KIP family, including p21 (CIP/WAF1), p27 (KIP1) and p57 (KIP2), with a broad specificity (5, 6) , and the other is the INK 4 family including p15 (INK4B), p16 (INK4A), p18 (INK4C) and p19 (INK4D), which target CDK4 and CDK6 (5) .
The primary substrates of CDK4/6 and CDK2 in G 1 progression are members of the retinoblastoma protein family, Rb, p107 and p130 (7, 8) . The hypophosphorylated Rb proteins bind to the E2F family of transcription factors, an important regulator of the cell cycle-progression, and keep them inactive during the M and G 0 phase. The activity of the Rb proteins is modulated by the sequential phosphorylation by CDK4/6-cyclin D and CDK2-cyclin E complexes (9) . The hyperphosphorylated Rb proteins release the E2F molecules, which next bind to their hypophosphorylated isoforms, allowing them to carry out their specific tasks in the G 1 /S phase progression (5) . Therefore, the growth arrest associated with differentiation could be achieved by several mechanisms including the down-regulation of CDKs, cyclins or the up-regulation of the CKIs or both.
In addition to the cell cycle arrest, an inducer of differentiation commonly deserves the therapeutic importance. Several compounds including dimethyl sulfoxide, retinoic acid, phorbol ester and 1,25-dihydroxy vitamin D 3 were known to induce acute promyelocytic leukemia (AML) cells to differentiate toward mature cells (10) . The HL-60 cell line, which was derived from an AML patient, provides a useful model system for examining the cellular and molecular events involved in the differentiation process (11) . The terminal differentiation of HL-60 cells can be monitored by the changes in the morphological, biochemical and immunological properties. The differentiated HL-60 phenotype is characterized by a growth inhibition, an increased adherence, a loss of the cell surface transferring receptors, an increase in the level of the monocytic surface markers, the induction of a-naphthyl acetate (nonspecific) esterase and certain patterns of protein phosphorylation (12) .
Therefore, as a part of our screening program to evaluate the chemopreventive potential effect of natural compounds, we investigated the effect of saucernetin-7 and saucernetin-8 ( Figure 1A ), which were isolated from Saururus chinensis (Saururaceae) and classified into dineolignans, on HL-60 cell growth. The whole plant of S.chinensis (Lour.) Baill (Saururaceae) has long been used for medicinal purposes as a result of its anti-inflammatory activity (13) . In addition, it was demonstrated previously that the methanol extract from S.chinensis inhibited the LPS-induced iNOS and COX-2 expression by blocking NF-kB activation (14) .
The anticancer effect and their molecular mechanism of saucernetin-7 and saucernetin- 8 have not yet been established although a similar structure of manassantin A was reported to have neuroleptic properties and cause a hypothermic response in mice (15) . Based on the cytotoxicity data, saucernetin-7 showed more significant effect than that of saucernetin-8. Here we report the effects of saucernetin-7 on the proliferation, cell cycle-regulation and differentiation of human leukemia HL-60 cells.
Materials and methods

Materials
The saucernetin-7 and saucernetin-8 used in this study was isolated from the underground parts of S.chinensis (2 kg) as described previously (14) . The physicochemical data of saucernetin-7 and saucernetin-8 are as follows. 165 (100) . The structures of these compounds were fully elucidated based on the spectroscopic methods and were confirmed by a comparison of their spectroscopic data with those reported in the literature (16) . The saucernetin-7 and saucernetin-8 isolated were checked by HPLC and were found to be 498% pure.
Cell culture and MTT assay
The P388 mouse leukemia, L-1210 mouse leukemia, 3LL Lewis mouse lung carcinoma, U-937 human histocytic lymphoma, HL-60 human promyelocytic leukemia, SNU-C5 human colon cancer and HepG2 human hepatoma cell lines were obtained from the Korean Cell Line Bank (KCLB, Seoul, Korea). The cells were cultured in RPMI 1640 medium (Life Technologies, Grand Island, NY) with 10% fetal bovine serum in a 37 C, CO 2 incubator in the presence or absence of the chemicals. The cytotoxicity was measured using a MTT assay. Briefly, the cells (5 Â 10 4 ) were seeded in each well containing 100 ml of the RPMI medium supplemented with 10% FBS in a 96-well plate. After 24 h, various concentrations of either saucernetin-7 or saucernetin-8 were added. After 48 h, 50 ml of MTT (5 mg/ml stock solution, Sigma, St Louis, MO) was added and the plates were incubated for an additional 4 h. The medium was discarded and the formazan blue, which was formed in the cells, was dissolved with 100 ml DMSO. The optical density was measured at 540 nm.
Growth inhibition assay
The in vitro growth inhibition effect of saucernetin-7 on the HL-60 cells was determined by using a cell proliferation enzyme-linked immunoassay (ELISA) system (version 2, Amersham Bioscience, Uppsala, Sweden) according to the manufacturer's instructions. Briefly, 2 Â 10 5 cells/ml were added to each well of the 96-well plates in the presence of various saucernetin-7 concentrations. After incubating the cells for 24EE72 h at 37 C, a 5-bromo-2 H -deoxyuridine (BrdU) labeling reagent was added, and the cells were incubated for an additional 2 h. The BrdU incorporated into the cellular DNA was stained with peroxidase-labeled anti-BrdU. After incubating the cells for 90 min, a 3,3 H ,5,5 H -tetramethylbenzidine substrate was added and the optical density was measured using an ELISA reader (Model Power Wave 340, Bio-Tek Instruments, Winooski, VT) at 450 nm.
Flow-cytometric cell analysis
The cell cycle-distribution has been described previously (17) . Briefly, the cells were collected by centrifugation at 1500 r.p.m. for 4 min. The cell pellets were then resuspended in 1 ml phosphate-buffered saline (PBS), fixed in 70% ice-cold ethanol and kept in a freezer overnight. The fixed cells were centrifuged, washed once in PBS and resuspended in 100 ml of a phosphateEEcitrate buffer for 30 min at room temperature to wash out any degraded DNA from the apoptotic cells. The cells were then collected by centrifugation at 2000 r.p.m., and the cell pellets were washed twice with PBS and resuspended in PBS containing 50 mg/ml propidium iodide and 100 mg/ml DNase-free RNase A. The cell suspension, which was hidden from light, was incubated for 30 min at 37 C and analyzed using the fluorescence-activated cell sorting (FACS) caterplus Flow cytometry (Becton Dickinson, Heidelberg, Germany).
Western blot analysis
Samples containing 30 mg of the total proteins were resolved by a 12% SDSEEPAGE, gel transferred onto a nitrocellulose membrane by electroblotting, and were then probed with anti-p21, anti-p27, anti-CDK2, anti-CDK4, anti-CDK6, anti-cyclin D1, anti-cyclin D2, anti-cyclin D3, anti-cyclin E, anti-Rb and anti-b actin antibodies (Santa Cruz Biotechnology, Santa Cruz, CA). The blots were developed using an enhanced chemiluminescence (ECL) kit (Amersham Bioscience, Uppsala, Sweden).
Immunoprecipitation
Samples of the total protein (100 mg) were incubated with the anti-CDK2, anti-CDK4 and anti-CDK6 polyclonal antibodies for 2 h at 4 C, followed by incubation with 20 ml of the protein A/GEESepharose beads (Sigma, St Louis, MO) for 1 h. The protein complexes were washed four times with an immunoprecipitation buffer [50 mM TrisEEHCl, pH 7.4, 0.5% NP-40, 150 mM NaCl, 50 mM NaF, 0.2 mM sodium orthovanadate, 1 mM dithiothreitol (DTT), 20 mg/ml aprotinin, 20 mg/ml leupeptin, 1 mM phenylmethylsulfonyl fluoride], and released from the beads by boiling in 2Â SDS sample buffer (125 mM TrisEEHCl, pH 6.8, 4% SDS, 10% b-mercaptoethanol, 2% glycerol, 0.02% bromophenolblue) for 5 min; the reaction mixture was then resolved by a 12% SDSEEPAGE gel, transferred onto a nitrocellulose membrane by electroblotting and probed with the anti-p21 monoclonal antibodies. The blot was developed using an ECL kit.
Kinase activity assay
The total lysates (500 mg protein) were prepared and immunoprecipitated with 5 mg each of anti-CDK2, anti-CDK4 and anti-CDK6 polyclonal antibodies as described above. Fifty microliters of protein AEESepharose CL-4B (Amersham Bioscience) prepared at 6 mg/ml in 0.1 M potassium phosphate buffer (pH 8.0), was added to each sample and incubated for 18 h at 4 C. Immunocomplexes were recovered by centrifugation for 30 min at 14 000 g and washed three times in a lysis buffer. The immunocomplexes were then resuspended and washed three times with a kinase buffer (50 mM TrisEEHCl, pH 7.4, 1 mM DTT, 10 mM MgCl 2 , 2.5 mM EDTA, 10 mM b-glycerophosphate, 1 mM NaF for CDK-4; 50 mM TrisEEHCl, pH 7.4, 1 mM DTT, 10 mM MgCl 2 for CDK-2). The kinase reactions were carried out in a final volume of 40 ml containing 20 mM ATP, 25 mCi [g-32 P]ATP, 2 mg histone H1 (Calbiochem, San Diego, CA) for CDK2 or 1 mg GSTEEretinoblastoma (Santa Cruz) for CDK4 and CDK6. The reactions were performed for 20 min at 30 C and quenched by adding an equal volume of a 2Â SDS loading buffer. After boiling for 10 min, the reaction products were separated by 12% SDSEEPAGE gel and the phosphorylated proteins were detected by autoradiography.
Reverse transcription PCR of p21 CIP1aWAF1
The total cellular RNA was isolated using Easy Blue Ò kits according to the manufacturer's instructions (iNtRON Biotechnology, Seoul, Korea). From each sample, 1 mg of RNA was reverse-transcribed using a MuLV reverse-transcriptase (Takara Biomedicals, Shiga, Japan), 1 mM deoxyribonucleoside triphosphates (dNTP), and 0.5 mg/ml of oligo (dT 12À18 ) (Bioneer, Seoul, Korea). The PCR analyses were then performed on the aliquots of the cDNA preparations to detect the p21 and b-actin gene expression using a thermal cycler (Perkin Elmer Cetus, Foster City, CA). The reactions were carried out in a volume of 25 ml containing (final concentration) 2 U of Taq DNA polymerase, 0.2 mM dNTP, Â10 reaction buffer and 100 pmol of 5 H and 3 H primers. For p21 amplification (18) , the PCR primers were 5 H to 3 H AGGAGGCCCGTGAG-CGATGGAAC and ACAAGTGGGGAGGAGGAAGTAGC (Bioneer). The PCR cycles were as follows: 1 min at 94 C for denaturation, 1 min at 59 C for annealing, 1 min at 72 C for polymerization, 26 cycles. For b-actin amplification, the PCR primers were 5 H to 3 H GATATCGCCGCGCTCGTCGTCGAG and CAGGAAGGAAGGCTGGAAGAGTGC (Bioneer). PCR cycles were as follows: 1 min at 94 C for denaturation, 1 min at 61 C for annealing, 1 min at 72 C for polymerization, 20 cycles. The PCR products were analyzed by 2.5% agarose gel electrophoresis and visualized by ethidium bromide staining and UV irradiation.
Differentiation assay (i) Nitrobluetetra-zolium (NBT) reduction test: the percentage of HL-60 cells capable of reducing NBT was measured by counting the number of cells containing the precipitated formazan particles after the cells had been incubated with the NBT (1.0 mg/ml) at 37 C for 30 min. 12-O-Tetradecanoylphorbol-13-acetate was used to stimulate the formation of formazan. (ii) Phagocytosis test: the HL-60 cells (1 Â 10 6 cells/ml) were suspended in serum-free RPMI 1640 medium containing 0.2% of the latex particles (average diameter, 0.81 mM) and incubated at 37 C for 4 h. After incubation, the cells were washed once with PBS. The cells containing 410 latex particles were scored as being phagocytic cells (19) . (iii) Esterase activity test: a smear preparation was chemically stained for a-naphthyl acetate esterase and naphthol AS-D chloroacetate esterase using the standard techniques (19) . (iv) Flow cytometry: the HL-60 cells (2 Â 10 5 cells/ml) exposed to saucernetin-7 were collected and washed twice with ice-cold PBS. The cells were then incubated with the direct FITC-labeled anti-CD 14 or anti-CD 66b antibodies (Pharmingen, San Diego, CA) on ice for 30 min, washed twice with PBS, and the level of antibody binding to the cells was quantified using FACS flow cytometry (Becton Dickinson).
Data analysis
The data are reported as a mean AE SD of the values from three independent determinations. All the experiments were done at least three times, each time with three or more independent observations. Statistical analysis was performed using a Student's t test.
Results
Effects of saucernetin-7 and saucernetin-8 on growth inhibition of HL-60 cells This study was initiated by examining the cytotoxicities of the saucernetin-7 and saucernetin-8 using a MTT assay on the various cancer cells (Table I ). The saucernetin-7 showed different degrees of cytotoxicity on these cells as judged by the IC 50 , and its values ranged from 3.7 to 29.4 mM, whereas saucernetin-8 showed a lower potency of inhibition (IC 50 , 15.4EE45.2 mM). Among the tested cancer cell lines, the HL-60 cells were the most vulnerable to saucernetin-7. The effect of saucernetin-7 on the proliferation of HL-60 cells was also examined using a cell proliferation ELISA system. The cell growth was inhibited in a concentrationand time-dependent manner ( Figure 1B) , showing the antiproliferative activity of saucernetin-7. The inhibitory effect became apparent at a concentration of 5 mM saucernetin-7, and no cytocidal effects were observed under this condition. Therefore, this concentration was used throughout the study.
Cell cycle-analysis and expression of cell cycle-regulatory proteins in HL-60 cells The effect of saucernetin-7 on the cell cycle in HL-60 cells was determined by FACS. As shown in Figure 2A , DNA flowcytometric analysis indicated that a saucernetin-7 treatment for 24 h led to a significant increase in the G 1 phase of the cell cycle, whereas a decrease in the G 2 /M and S phase was detected. In addition, saucernetin-7 induced the cell cycle arrest in HL-60 cells in a time-dependent manner ( Figure  2B ). The CDK4/6-cyclin D and CDK2-cyclin E protein levels were next examined under the same conditions because CDK4 and CDK6 are believed to be involved in the early G 1 , whereas CDK2 is necessary to complete the G 1 phase and initiate the S phase. Saucernetin-7 down-regulated the CDK6 and cyclin D1 protein levels, whereas CDK2, CDK4, cyclin D2, D3 and cyclin E were unaffected ( Figure 2C ). Therefore, these results indicate that the inhibitory effect of saucernetin-7 on cell proliferation is a result of the induction of the G 1 phase arrest of the HL-60 cell cycle through changes in the G 1 phase-regulatory proteins. Exponentially growing cells were treated with the indicated concentration of saucernetin-7 for 72 h (filled circle, control; filled square, 2.5 mM; filled triangle, 5 mM; filled diamond, 10 mM; * , 20 mM). Cell growth inhibition was assessed by a BrdU incorporation assay as described in Materials and methods. The growth of the HL-60 cells was significantly inhibited in a dose-dependent manner. The data represent the mean AE SD of three independent experiments.
Saucernetin induces differentiation via cell cycle arrest
Effect of saucernetin-7 on p21 CIPaWAF1 and p27 KIP1 expression in HL-60 cells Because saucernetin-7 induced a G 1 arrest in HL-60 cells, we next examined the change in the p21
CIP1aWAF1 and p27 KIP1 proteins, which are the CKIs related with the G 1 phase arrest. The p21 CIP1aWAF1 protein level increased in a time-dependent manner, whereas no detectable change was observed in the p27 KIP1 level ( Figure 3A ). In accordance with the protein level, the p21
CIP1aWAF1 mRNA level also increased in a timedependent manner as evaluated by the semi-quantitative RTEEPCR ( Figure 3B ). In order to determine if the increase in the p21
CIP1aWAF1 mRNA level is due to either the up-regulation of p21
CIP1aWAF1 gene expression or an increase in the p21
CIP1aWAF1 mRNA stability, the HL-60 cells were incubated for the indicated time period in the presence or absence of 4 mg/ml actinomycin D (transcription inhibitor) following a 48 h treatment with 5 mM saucernetin-7. The saucernetin-7-induced p21
CIP1aWAF1 mRNA became barely detectable after 4 h incubation with actinomycin D, indicating that an increase in the p21
CIP1aWAF1 mRNA level was due to the transcriptional up-regulation of p21
CIP1aWAF1 gene expression.
Effect of saucernetin-7 on the p21
CIPaWAF1 level of the CDK immune complex and on the CDK-associated kinase activity Next, we questioned whether or not saucernetin-7-induced p21
CIP1aWAF1 would be detected in the complexes with the CDKs during the cell cycle. The CDK2, CDK4 and CDK6 complexes were immunoprecipitated from the HL-60 cells, which were either treated or not treated with saucernetin-7, and the co-immunoprecipitated p21
CIP1aWAF1 level in each immune complex was determined by western blot analysis using anti-p21 antibodies. As shown in Figure 4A , the p21
CIP1aWAF1 levels in the CDK2 and CDK6 immune complex of the saucernetin-7-treated cells were distinctively higher than in those of the untreated cells. However, there was essentially no difference in the p21
CIP1aWAF1 level of the CDK4 immune complex regardless of the saucernetin-7 treatment.
Such changes in the p21
CIP1aWAF1 level in each CDK complex was inversely correlated with the in vitro CDK kinase activity, which was directly measured by an immune complex using the histone H1 (for CDK2) or GST-Rb fusion protein (for CDK 4 and CDK6) as substrates; the CDK2-and CDK6-associated kinase activity dramatically decreased in the HL-60 cells, which were treated with saucernetin-7 ( Figure 4B ). The CDK4 activity was not altered in response to saucernetin-7. In addition, the decrease in the CDK2 and CDK6-associated kinase activity was associated with the underphosphorylation of the Rb protein ( Figure 4C ). Collectively, these results suggest that the p21
CIP1aWAF1 protein might play a key role in the G 1 phase arrest although it increased binding to CDK2 and CDK6 in the saucernetin-7-treated HL-60 cells, which leads to the down-regulation of CDK2 and CDK6 kinase activity and hence to the cell cycle arrest.
Effect of saucernetin-7 on differentiation of HL-60 cells
In order to determine whether the growth inhibition of HL-60 cells by saucernetin-7 is associated with terminal differentiation, the HL-60 cells were incubated with saucernetin-7 at a concentration of 2.5 and 5 mM for 72 h. As shown in Table II The protein extracts were harvested from HL-60 cells exposed to 5 mM saucernetin-7 for the indicated time period and were subjected to western blot analysis using the specific antibodies for the cell cycle-related proteins. The experiments were repeated three times with similar results.
NBT-reproducible cell rate of 36.5%. Treatment of the HL-60 cells with 5 mM saucernetin-7 for 72 h resulted in a 38.1% increase of naphthyl AS-D chloroacetate esterase, but the effect on the a-naphthyl acetate esterase activity was relatively mild. Moreover, the cells treated with these compounds showed an apparent phagocytic activity. In addition, as shown in Figure 5A , 5 mM saucernetin-7 significantly increased the expression of both membrane antigens, CD14 and CD66b. When the morphological changes were observed by Wright-Giemsa staining, the saucernetin-7-treated cells became larger and exhibited granulation appearance, which are a characteristic of differentiated cells, such as the monocyte/marcrophage and granulocytes ( Figure 5C ). Therefore, we concluded that saucernetin-7 induced differentiation of human promyelocytic leukemia cells to myelocyte/marcrophage and granulocytes.
Discussion
This study demonstrates that saucernetin-7 potently causes the cell cycle arrest in the HL-60 cells, leading to the inhibition of the cell proliferation and the induction of differentiation. When the structural characteristic of saucernetin-7 was compared with that of saucernetin-8, saucernetin-7 has methylenedioxy and 3,4-dimethoxy substituents in the side chains resulting in the dissymmetric structure, while saucernetin-8 has a C-2 symmetric structure by the same 3,4-dimethoxy substituents in the side chains. Based on these points, it is speculated that the cytotoxicity of saucernetin-7 may be due to the methylenedioxy substituent or the dissymmetric structure. We first observed that saucernetin-7 inhibited the HL-60 cell proliferation in a dose-and time-dependent manner, which was assessed by the cell proliferation ELISA system ( Figure 1B ). This observation prompted us to investigate the effect of saucernetin-7 on the cell cycle-regulation and the characteristics of HL-60 differentiation.
The cell cycle-analysis revealed that saucernetin-7 could markedly induce a G 1 phase arrest in HL-60 cells, but there was reduction effect on the G 2 /M and S phase. Therefore, we next investigated the G 1 phase-related cell cycle-regulators, CKIs, CDKs and cyclins. First, the G 1 phase arrest in the HL-60 cells was associated with a marked up-regulation of the p21
CIP1aWAF1 protein and mRNA. Since the p21
CIP1aWAF1 mRNA level depends not only on the gene transcriptional activity but also on mRNA stability, we further examined whether or not saucernetin-7 increased the stability of p21 mRNA through a treatment of 4 mg/ml actinomycin D, a transcription inhibitor. Actinomycin D markedly inhibited the saucernetin-7-induced p21 mRNA expression level. This result indicated that p21 CIP1aWAF1 mRNA was transcriptionally up-regulated by saucernetin-7, and saucernetin-7 does not stabilize the p21
CIP1aWAF1 message. The increased p21
CIP1aWAF1 level in the quiescent and terminally differentiation cells suggests that this protein plays a crucial role in preventing the cells from re-entering the cell cycle, which is an absolute requirement for terminal differentiation (20, 21) . The induction of p21
CIP1aWAF1 by DNA damage requires p53 (22) . However, the p21
CIP1aWAF1 gene can also be up-regulated via the p53-independent pathways by serum stimulation (21) as well as during cellular senescence (23) and differentiation (21) . Saucernetin-7 rapidly enhanced the p21
CIP1aWAF1 gene expression level in HL-60 cells after 24 h, where the p53 gene was deleted, and the gene expression was absent (24) . Therefore, a p53-independent pathway exists in the induction of p21 CIP1aWAF1 by saucernetin-7. Recent studies have demonstrated that the induction of p21 CIP1aWAF1 depends on Raf/Erk signaling (24, 25) and protein kinase C (PKC) signaling (26) . In addition, AP-1 is known to bind directly to the promoter region of the p21
CIP1aWAF1 gene, and thus regulates the expression level of this gene (27) . Indeed, we examined the effect of extracellular signal-regulated protein kinase (ERK) MAP kinase, p38 MAP kinase, PKC and phosphatidylinositol-3-OH kinase (PI3K) on saucernetin-7-induced p21 CIP1aWAF1 protein level. However, the 
p21
CIP1aWAF1 protein level was unaffected by a pre-treatment with 20 mM U0126 (a specific inhibitor of the mitogenactivated protein kinase 1 and 2), 10 mM SB203580 (a specific inhibitor of p38 MAP kinase), 20 mM LY294002 (a specific PI3K inhibitor) and 1 mM GF109203 (a specific PKC inhibitor) (data not shown). Therefore, saucernetin-7 is likely to upregulate p21
CIP1aWAF1 transcription through a pathway that is independent of these kinase signal pathways in HL-60 cells.
Among the CDKs that regulate the cell cycle, CDK2, CDK4 and CDK6 are activated in association with the D-type cyclins or cyclin E during the G 1 progression and the G 1 EES transition. This study revealed that the CDK6 and cyclin D1 expression levels were decreased in the saucernetin-7-treated HL-60 cells, but those of CDK2, CDK4, cyclin D2, cyclin D3 and cyclin E were not. In addition, the accumulation of the p21 CIP1aWAF1 protein in association with the G 1 arrest was detected largely in the complexes with CDK2 and CDK6. The decreased CDK6 and cyclin D1 level and the increased forms of the p21
CIP1aWAF1 -CDK2 and p21 CIP1aWAF1 -CDK6 complexes support the notion that saucernetin-7 markedly decreased the CDK2-and CDK6-associated kinase activity in the HL-60 cells. Furthermore, the reduced kinase activities of CDK2 and CDK6 were accompanied by the under-phosphorylation of the Rb protein, which is known to sequester the transcription factor, E2F, thereby preventing the cells from further entering the cell cycle-progression. Overall, the blocking G 1 in the HL-60 cells from entry into the S-phase appears to be mediated by the down-regulation of the CDK2-and CDK6-associated kinase activity in association with the induction of CKI, p21
CIP1aWAF1 . These anti-proliferative effects were also related to the terminal differentiation. Terminal differentiation in the diverse cell types occurring either spontaneously or as a consequence of a treatment with the specific inducing agents correlates with an irreversible loss of the proliferative potential (17) . In this regard, the differentiation effect of saucernetin-7 was examined in the present study. Saucernetin-7 significantly induced differentiation in the HL-60 promyelocytic leukemia cells, which are widely used as a model system for the differentiation study. This effect of saucernetin-7 was confirmed with a NBT reduction test, esterase activity assay, phagocytosis and expression of cell surface antigens. These results indicate that saucernetin-7 is a new potent inducer of differentiation on the HL-60 human leukemia cells to monocyte/marcrophage and granulocyte. To our knowledge, this is a first demonstration that saucernetin-7 exerts an anti-proliferative effect via cell cycle arrest, which precedes a differentiation-inducing effect on the HL-60 cells.
In summary, saucernetin-7 inhibits the cell proliferation of HL-60 cells by not only arresting the G 1 phase cell cycle through the down-regulation of the CDK2-and CDK6-associated kinase activity in association with the induction of 
CKI, p21
CIP1aWAF1 but also inducing differentiation. Finally, these results suggest that saucernetin-7 may be useful as one of the investigational drugs for treating leukemia patients.
